TEST BANK PHARMACOLOGY AND THE
| | | |
NURSING PROCESS 9TH EDITION 58
| | | | |
CHAPTERS LINDA LANE LILLEY, SHELLY
| | | | |
RAINFORTH COLLINS, JULIE S. SNYDER
| | | | | |
, Chapter 01: The Nursing Process and Drug Therapy | | | | | | |
MULTIPLE CHOICE |
1. During an intravenous (IV) infusion of amphotericin B, a patient develops
| | | | | | | | | |
tinglingand numbnessin his toes and fingers. What will the nurse do first?
| | | | | | | | | | | | |
a. Discontinue the infusion immediately. | | |
b. Reduce the infusion rate gradually until the adverse | | | | | | |
effectssubside.
| |
c. Administer the medication by rapid IV infusion to | | | | | | |
reducethese effects.
| | |
d. Nothing; these are expected side effects of this medication. | | | | | | | |
ANS: A |
Once the intravenous infusion of amphotericin B has begun, vital signs must be
| | | | | | | | | | | |
| monitored frequently to assess for adverse reactions such as cardiac
| | | | | | | | |
dysrhythmias,visual disturbances, paresthesias (numbness or tingling of the hands
| | | | | | | | | |
or feet), respiratory difficulty, pain, fever, chills,and nausea. If these adverse effects
| | | | | | | | | | | |
or a severe reaction occur, the infusion must be discontinued(while the patient is
| | | | | | | | | | | | |
closely monitored) and the prescriber contacted. The other options are incorrect.
| | | | | | | | | | |
DIF: COGNITIVE LEVEL: Applying
| | |
(Application)TOP:
| NURSINGPROCESS: Implementation | |
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
| | | | | | |
The nurse is writing a nursing diagnosis for a plan of care for a patient who has
| | | | | | | | | | | | | | | |
?
,been newlydiagnosed with type 2 diabetes. Which statement reflects
| | | | | | | | |
thecorrect format for a nursing diagnosis?
| | | | | | |
a. Anxiety
b. Anxiety related to new drug therapy | | | | |
c. Anxiety related to anxious feelings about drug therapy, as evidenced
| | | | | | | | |
| bystatements
|
such as “I’m upset about having to test my blood sugars.”
| | | | | | | | | |
d. Anxiety related to new drug therapy, as evidenced by statements such
| | | | | | | | | |
| as“I’m
|
upset about having to test my blood sugars.”
| | | | | | |
ANS: D |
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” ismissing
| | | | | | | | | | |
the
|
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety
| | | | | | | | | |
related to new drug therapy” is missing the “as evidenced by” portion of
| | | | | | | | | | | | |
definingcharacteristics. The statementbeginning “Anxiety related to anxious
| | | | | | | |
feelings” is incorrect because the “related to” section is simply a restatement of the
| | | | | | | | | | | | | |
problem “anxiety,” not a separate factor related to the response.
| | | | | | | | | |
DIF: COGNITIVE LEVEL: Understanding
| | |
?
, (Comprehension)TOP: NURSING PROCESS: | |
Nursing Diagnosis |
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
| | | | | | | | |
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the
| | | | | | | | | | | |
nurse was busy andgave the medication 2 hours after the scheduled dose was due.
| | | | | | | | | | | | | |
Whattype of problem does this represent?
| | | | | | |
a. “Right time” |
b. “Right dose” |
c. “Right route” |
d. “Right
medication”
ANS: A |
“Right time” is correct because the medication was given more than 30
| | | | | | | | | | |
| minutes after the scheduled dose was due. “Dose” is incorrect because
| | | | | | | | | |
thedose is not related to the time the
| | | | | | | | |
medication administration is scheduled. “Route” is incorrect because the routeis
| | | | | | | | | |
not affected.“Medication” is incorrect because the medication ordered will not
| | | | | | | | | |
change.
|
DIF: COGNITIVE LEVEL: Applying
| | |
(Application)TOP:
| NURSINGPROCESS: Implementation | |
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
| | | | | | | | | |
3. The nurse has been monitoring the patient’s progress on a new drug
| | | | | | | | | | |
regimensince the first doseand documenting the patient’s therapeutic response
| | | | | | | | | |
to the
| |
?
| | | |
NURSING PROCESS 9TH EDITION 58
| | | | |
CHAPTERS LINDA LANE LILLEY, SHELLY
| | | | |
RAINFORTH COLLINS, JULIE S. SNYDER
| | | | | |
, Chapter 01: The Nursing Process and Drug Therapy | | | | | | |
MULTIPLE CHOICE |
1. During an intravenous (IV) infusion of amphotericin B, a patient develops
| | | | | | | | | |
tinglingand numbnessin his toes and fingers. What will the nurse do first?
| | | | | | | | | | | | |
a. Discontinue the infusion immediately. | | |
b. Reduce the infusion rate gradually until the adverse | | | | | | |
effectssubside.
| |
c. Administer the medication by rapid IV infusion to | | | | | | |
reducethese effects.
| | |
d. Nothing; these are expected side effects of this medication. | | | | | | | |
ANS: A |
Once the intravenous infusion of amphotericin B has begun, vital signs must be
| | | | | | | | | | | |
| monitored frequently to assess for adverse reactions such as cardiac
| | | | | | | | |
dysrhythmias,visual disturbances, paresthesias (numbness or tingling of the hands
| | | | | | | | | |
or feet), respiratory difficulty, pain, fever, chills,and nausea. If these adverse effects
| | | | | | | | | | | |
or a severe reaction occur, the infusion must be discontinued(while the patient is
| | | | | | | | | | | | |
closely monitored) and the prescriber contacted. The other options are incorrect.
| | | | | | | | | | |
DIF: COGNITIVE LEVEL: Applying
| | |
(Application)TOP:
| NURSINGPROCESS: Implementation | |
MSC: NCLEX: Physiological Integrity: Pharmacological and Parenteral Therapies
| | | | | | |
The nurse is writing a nursing diagnosis for a plan of care for a patient who has
| | | | | | | | | | | | | | | |
?
,been newlydiagnosed with type 2 diabetes. Which statement reflects
| | | | | | | | |
thecorrect format for a nursing diagnosis?
| | | | | | |
a. Anxiety
b. Anxiety related to new drug therapy | | | | |
c. Anxiety related to anxious feelings about drug therapy, as evidenced
| | | | | | | | |
| bystatements
|
such as “I’m upset about having to test my blood sugars.”
| | | | | | | | | |
d. Anxiety related to new drug therapy, as evidenced by statements such
| | | | | | | | | |
| as“I’m
|
upset about having to test my blood sugars.”
| | | | | | |
ANS: D |
Formulation of nursing diagnoses is usually a three-step process. “Anxiety” ismissing
| | | | | | | | | | |
the
|
“related to” and “as evidenced by” portions of defining characteristics. “Anxiety
| | | | | | | | | |
related to new drug therapy” is missing the “as evidenced by” portion of
| | | | | | | | | | | | |
definingcharacteristics. The statementbeginning “Anxiety related to anxious
| | | | | | | |
feelings” is incorrect because the “related to” section is simply a restatement of the
| | | | | | | | | | | | | |
problem “anxiety,” not a separate factor related to the response.
| | | | | | | | | |
DIF: COGNITIVE LEVEL: Understanding
| | |
?
, (Comprehension)TOP: NURSING PROCESS: | |
Nursing Diagnosis |
MSC: NCLEX: Safe and Effective Care Environment: Management of Care
| | | | | | | | |
2. The patient is to receive oral guaifenesin (Mucinex) twice a day. Today, the
| | | | | | | | | | | |
nurse was busy andgave the medication 2 hours after the scheduled dose was due.
| | | | | | | | | | | | | |
Whattype of problem does this represent?
| | | | | | |
a. “Right time” |
b. “Right dose” |
c. “Right route” |
d. “Right
medication”
ANS: A |
“Right time” is correct because the medication was given more than 30
| | | | | | | | | | |
| minutes after the scheduled dose was due. “Dose” is incorrect because
| | | | | | | | | |
thedose is not related to the time the
| | | | | | | | |
medication administration is scheduled. “Route” is incorrect because the routeis
| | | | | | | | | |
not affected.“Medication” is incorrect because the medication ordered will not
| | | | | | | | | |
change.
|
DIF: COGNITIVE LEVEL: Applying
| | |
(Application)TOP:
| NURSINGPROCESS: Implementation | |
MSC: NCLEX: Safe and Effective Care Environment: Safety and Infection Control
| | | | | | | | | |
3. The nurse has been monitoring the patient’s progress on a new drug
| | | | | | | | | | |
regimensince the first doseand documenting the patient’s therapeutic response
| | | | | | | | | |
to the
| |
?
